← FDA Drug Approvals (Drugs@FDA)

ADCETRIS

BLA · Biologics License Application · Sponsor: SEATTLE GENETICS · Approved 2011-08-19

Drug application

FDA Application #

BLA125399

Application type

Biologics License Application

Brand name

ADCETRIS

Generic name

Brentuximab Vedotin

Active ingredients

BRENTUXIMAB VEDOTIN

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

SEATTLE GENETICS

First approval

2011-08-19

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown